Raymond schinazi net worth
Raymond F. Schinazi is an American organic medicinal chemist with expertise in antiviral agents, pharmacology, and biotechnology. His research focuses on developing treatments for infections caused by human immunodeficiency virus (HIV), hepatitis B (HBV), hepatitis C (HCV), herpes, dengue fever, zika, chikungunya, and other emerging viruses. These treatment options include antiviral agents as well as synthetic, biochemical, pharmacological and molecular genetic approaches, in… WebSep 5, 2024 · Professor Raymond Schinazi is a scientist whose research focuses on developing treatments for life-threatening viruses. He’s widely recognised for his contributions in the fields of HIV and hepatitis B. In fact, more than 94% of HIV-infected individuals take at least one of the drugs he invented.
Raymond schinazi net worth
Did you know?
WebHis net worth has been growing significantly in 2024-2024. So, how much is Raymond F. Schinazi worth at the age of 70 years old? Raymond F. Schinazi’s income source is … WebMay 12, 2024 · The estimated Net Worth of Raymond F Schinazi is at least Precision BioSciences stock worth over $8,979,703 and over the last 8 years Raymond sold DTIL …
WebAug 20, 2015 · Raymond Schinazi, drug-development pioneer, earns VA's highest honor for biomedical research. August 20, 2015. Dr. Raymond Schinazi, a researcher with the Atlanta VA and Emory University, received VA's 2015 Middleton Award for his development of drugs to treat HIV, hepatitis B, and hepatitis C infections. WebSchinazi is the founder of several biotechnology companies focusing on antiviral drug discovery and development, including Pharmasset Inc., Triangle Pharmaceuticals (acquired by Gilead in 2003), Idenix Pharmaceuticals (51% acquired by Novartis in 2003), and RFS Pharma LLC (formed in Sept 2004). He holds more than 70 US patents.
WebMay 12, 2024 · The estimated Net Worth of Raymond F Schinazi is at least Precision BioSciences stock worth over 12,663,684$ and over the last 7 years Raymond sold DTIL stock worth over 1,696,250 WebMay 12, 2024 · The estimated Net Worth of Raymond F Schinazi is at least Precision BioSciences stock worth over 12,663,684$ and over the last 7 years Raymond sold DTIL …
WebDisclamer: Raymond F. Schinazi net worth are calculated by comparing Raymond F. Schinazi's influence on Google, Wikipedia, Youtube, Twitter, Instagram and Facebook with …
WebRaymond F Schinazi Currently, there are two safe and effective therapeutic strategies for chronic hepatitis B treatment, namely, nucleoside analogs and interferon alpha (pegylated or non-pegylated). incarnate word assisted living san antonioWebThe estimated net worth of Raymond F. Schinazi is at least $14.20 million as of May 4th, 2024. Mr. Schinazi owns 7,674,960 shares of Cocrystal Pharma stock worth more than … in christ\u0027s love signatureWebRaymond F Schinazi Currently, there are two safe and effective therapeutic strategies for chronic hepatitis B treatment, namely, nucleoside analogs and interferon alpha (pegylated … incarnate word athletic directorWebRaymond F Schinazi And Family Foundation Inc: Employer Identification Number (EIN) 203693012: ... Net investment income Adjusted net income Disbursements for charitable purposes ... Net value of noncharitable-use assets: $3,320,124: $9,866,296: Minimum investment return: $74,504: $166,006: in christ you have been brought to fullnessWebMay 12, 2024 · The estimated Net Worth of Raymond F Schinazi is at least Precision BioSciences stock worth over $9,440,201 and over the last 8 years Raymond sold DTIL stock worth over $1,696,250 in christ you are a new creation kjvWebMay 6, 2024 · The current estimated net worth of Cocrystal Pharma, Inc's Raymond F Schinazi is estimated to be about $22.45M . Raymond F Schinazi owns about 7,674,960 … incarnate word athletic staffWebIn this section, we analyze the profitability of every unplanned, open-market insider purchase made by Raymond F Schinazi in COCP / Cocrystal Pharma Inc. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are ... incarnate word at north dakota state